Tag: Drug Development

Drug development is the process of bringing a new pharmaceutical drug to the market once a lead compound has been identified through the process of drug discovery. It includes pre-clinical research on microorganisms and animals, filing for regulatory status for an investigational new drug to initiate clinical trials on humans, and may include the step of obtaining regulatory approval with a new drug application to market the drug.

Novo Holdings Invests over $10m in New Antibiotics’ Development

Small-molecule therapeutics company Curza received $5.25 million from the Novo Holdings REPAIR Impact Fund to help accelerate its lead programme focusing on a new class of antibiotics targeting drug-r...

Servier Australia and BioCurate Agreed to Share Expertise to Accelerate the Discovery of New Drugs

Servier Australia, the subsidiary of Servier Group, an international pharmaceutical company, and BioCurate, a joint venture company of Monash University and The University of Melbourne with support fr...

Cooperation on Development of Immuno-Oncology Therapies Announced by Gilead and Carna Biosciences

gilead sciences
Gilead Sciences, Inc. and Carna Biosciences Inc. announced that the companies have entered into a research and development collaboration to develop and commercialize small molecule compounds in immuno...

Cytel and Axio to Create Industry Leader in Analytical Solutions for Drug Development

Cytel Inc., the leading global provider of innovative analytical software and services to the life sciences industry, and Axio Research, a premier provider of biostatistics to pharmaceutical, biotechn...

Teijin and AMED Agreed Partnership to Develop Drugs for Frail

Teijin Limited announced that it has signed a research and development agreement with the Japan Agency for Medical Research and Development (AMED) to form an industry-government-academia partnership t...

AstraZeneca Announce Cooperation to Accelerate Drug Discovery

astrazeneca
AstraZeneca and BenevolentAI began a long-term collaboration to use artificial intelligence (AI) and machine learning for the discovery and development of new treatments for chronic kidney disea...

LabCorp and Envigo in Acquisition Deal

LabCorp®, a leading global life sciences company that is deeply integrated in guiding patient care, and Envigo, a leading provider of nonclinical contract research services and research models, announ...

Launch of Medicines Discovery Institute for Novel Meds Development

With the launch of Medicines Discovery Institute, Cardiff University has stepped up the development of new drugs for mental health and central nervous system conditions. The new institute aims to deve...

PPD and HLT of China in Exclusive Agreement

Pharmaceutical Product Development, LLC (PPD) and Happy Life Tech (HLT) of China have signed an exclusive agreement to develop a distinctive service offering for the China drug-development market deli...

IQVIA Launches Services for Emerging Biopharma Needs

IQVIA has launched IQVIA Biotech and its new approach to providing clinical and commercial services for small biotech and biopharma companies. The solutions suite will provide simplified operating pro...

GM Chickens Produce Human Proteins

Genetically modified (GM) chickens could be used as a cheaper way to produce certain types of drugs compared to traditional manufacturing methods, research suggests. A team from The University of E...

Aquinnah will Advance Drug Development for Tauopathy

Aquinnah Pharmaceuticals got $750,000 from the Tau Pipeline Enabling Program (T-PEP) to advance its drug development programs in tauopathy diseases. In the announcement, the company noted that the ...

Elevian and Insilico to Discover Anti-Aging Drugs

Elevian and Insilico Medicine have announced a research and development partnership to develop oral medications targeting the GDF11 pathway and associated targets. Elevian is an emerging biotech co...

English and Indian Companies Collaboration

agreement
Edinburgh, Scotland-based mental health and neurology research company Caritas Neuro Solutions has signed a landmark partnership agreement with Mumbai, India-based digitally driven organisation Innvoc...

FDA Creates Drug Development Science Office

The FDA will develop more standardized, streamlined, and structured processes for reviewing new drugs, FDA commissioner Dr. Scott Gottlieb announced Tuesday. To do that, the agency will create a ne...

Pfizer will Use CytoReason’s Machine Learning Models for Drug Discovery

pfizer
CytoReason, a leader in machine learning for drug discovery and development, announced that it has entered into a collaboration agreement with Pfizer Inc. that will leverage CytoReason’s cell-centered...